Chemoinformaics analysis of alpha-eleostearic-acid
| Molecular Weight | 216.24 | nRot | 1 |
| Heavy Atom Molecular Weight | 204.144 | nRig | 16 |
| Exact Molecular Weight | 216.09 | nRing | 3 |
| Solubility: LogS | -3.076 | nHRing | 2 |
| Solubility: LogP | 2.321 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 31.8455 |
| nHD | 2 | BPOL | 15.7825 |
| QED | 0.758 |
| Synth | 2.36 |
| Natural Product Likeliness | 0.517 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.968 |
| HIA | 0.006 |
| CACO-2 | -5.014 |
| MDCK | 0.00000838 |
| BBB | 0.933 |
| PPB | 0.646246 |
| VDSS | 1.308 |
| FU | 0.241165 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.912 |
| CYP2c19-inh | 0.516 |
| CYP2c19-sub | 0.388 |
| CYP2c9-inh | 0.179 |
| CYP2c9-sub | 0.933 |
| CYP2d6-inh | 0.489 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.301 |
| CYP3a4-sub | 0.234 |
| CL | 7.715 |
| T12 | 0.603 |
| hERG | 0.054 |
| Ames | 0.628 |
| ROA | 0.695 |
| SkinSen | 0.445 |
| Carcinogencity | 0.061 |
| EI | 0.219 |
| Respiratory | 0.889 |
| NR-Aromatase | 0.079 |
| Antiviral | No |
| Prediction | 0.72455 |